Inventor · disambiguated record
Xiaoqing Xu
Also filed as: XU XIAOQING
11 granted patents·1 pending application·57 citations·filing 2004–2017
87Inventor score
Files withJANSSEN PHARMACEUTICA NV5COLBURN RAYMOND W3DAVIS BENJAMIN1JETTER MICHELE C1MACIELAG MARK J1
Top patents by PatentIndex Score
12 records- 0188US8324217B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2012·Granted Dec 4, 2012·13 cites·11 claims
- 0288US8143259B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Mar 27, 2012·13 cites·24 claims
- 0386US8653099B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Feb 18, 2014·9 cites·27 claims
- 0481US10654834B2Non-systemic TGR5 agonistsVENENUM BIODESIGN LLC·Filed 2017·Granted May 19, 2020·3 cites·20 claims
- 0580US7732612B27-amino alkylidenyl-heterocyclic quinolones and naphthyridonesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jun 8, 2010·3 cites·12 claims
- 0680US7179805B27-amino alkylidenyl-heterocyclic quinolones and naphthyridonesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 20, 2007·15 cites·14 claims
- 0761US8242157B2Benzimidazole derivatives useful as TRPM8 channel modulatorsJETTER MICHELE C·Filed 2010·Granted Aug 14, 2012·1 cites·3 claims
- 0858US8981113B2Benzimidazole derivatives useful as TRPM8 channel modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 17, 2015·0 cites·10 claims
- 0957US9096521B2Cold menthol receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 4, 2015·0 cites·21 claims
- 1052US2009156577A17-amino alkylidenyl-heterocyclic quinolones and naphthyridonesDAVIS BENJAMIN·Filed 2008·Application pending·0 cites
- 1148US9636345B2Benzimidazole derivatives useful TRPM8 channel modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted May 2, 2017·0 cites·1 claims
- 1248US8450497B2Benzimidazole derivatives useful as TRPM8 channel modulatorsMACIELAG MARK J·Filed 2010·Granted May 28, 2013·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Xiaoqing Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →